Gene targeting in embryonic stem cells was used to secretory granules. However, the release of insulin from generate UCP2-deficient mice. Homozygous (Ϫ/Ϫ) anisecretory granules in response to the minute-to-minute mals failed to express intact UCP2 mRNA in all tissues fluctuations in blood glucose depends on a complex tested, including pancreatic islets. UCP2 mRNA was signal transduction pathway linked to glucose metaboreduced in islets isolated from heterozygous (ϩ/Ϫ) anilism (Ashcroft and Gribble, 1999). mals compared with controls. Deficiency of UCP2 had Like other cells, pancreatic ␤ cells metabolize glucose no effects on body weight or cold-induced thermogeneto yield ATP. The metabolism of glucose generates elecsis in the mutant mice. The mice lacking UCP2 had tron carriers (such as NADH) that shuttle to the inner significantly lower glucose levels and higher insulin semembrane of the mitochondrion, where they donate cretion rates under basal conditions and following intraelectrons to the electron transport chain. As electrons peritoneal and intravenous glucose administration. Panmove down this chain, protons are pumped out of the creatic islets isolated from the homozygous (Ϫ/Ϫ) mitochondrial matrix by complexes I, III, and IV, creating animals secreted more insulin and demonstrated higher a proton electrochemical gradient (Scheffler, 1999). The levels of ATP than control animals. These results sugpotential energy in this gradient is used by ATP synthase gest that the level of Ucp2 gene expression in the panto produce ATP from ADP. In the ␤ cell, the increase in creatic ␤ cell is an important determinant of the sensitivthe ATP/ADP ratio that results from glucose metabolism ity of insulin secretion to changes in glucose. closes a membrane ATP-sensitive potassium channel, On the basis of additional studies performed in ob/ causing membrane depolarization, calcium influx, and ob mice, a model of type 2 diabetes, the authors suggest insulin secretion. Normally, the generation of ATP is that UCP2 is a major link between obesity, ␤ cell dystightly coupled to the metabolism of glucose and the function, and type 2 diabetes. UCP2 mRNA and protein two processes proceed in parallel. Thus, the secretion were upregulated in pancreatic islets from ob/ob mice. of insulin is linked to the rate of glucose metabolism Although serum insulin levels were elevated 33-fold in through oxidative phosphorylation. Defects in oxidative these animals, even this marked degree of hyperinsulinphosphorylation would be expected to impair insulin emia was insufficient to compensate for the profound secretion. Consistent with this notion, mitochondrial insulin resistance, resulting in significant hyperglycemia, mutations cause maternally inherited type 2 diabetes particularly following glucose administration. When due to defects in insulin secretion (Guillausseau et al., mice lacking UCP2 were crossed with ob/ob mice, the 2001; Velho et al., 1996). Uncoupling glucose metaboresulting reduction in UCP2 expression in the ob/ob lism from ATP generation would also be expected to animals was associated with a marked improvement in impair the ability of the ␤ cell to secrete insulin in reglucose tolerance. This genetically induced reduction sponse to glucose. Reducing the extent of uncoupling of UCP2 levels in ob/ob mice had effects on insulin would be expected to increase insulin secretion.
icantly higher, suggesting a significant improvement in populations, insulin resistant obese subjects are able to maintain normal glucose tolerance for prolonged perithe rapid insulin secretory response to glucose. On the basis of these results, the authors conclude that the ods of time through this mechanism of ␤ cell compensation. In a proportion of subjects, compensation fails, improvement in glucose tolerance seen in the ob/ob mice when a reduction in UCP2 levels was genetically insulin concentrations fall, and glucose concentrations rise, eventually leading to diabetes. Does increased induced is due to enhanced insulin secretion. A note of caution appears to be warranted before a definitive UCP2 expression contribute to this failure of ␤ cell compensation for insulin resistance? Although the possibility conclusion is reached on this important point. The effects of lowering UCP2 levels in ob/ob mice on serum is intriguing, based on the data in the present paper in Cell (Zhang et al., 2001 ), the effects may be subtle. Deinsulin levels were complex, and insulin concentrations were either increased or decreased depending on the spite increased expression of UCP2 in pancreatic ␤ cells, insulin concentrations were over 30-fold greater physiological state under which the animals were studied, as well as the prevailing blood glucose concentrathan control in ob/ob mice, indicating that increased expression of UCP2 is still compatible with substantial tions. Since the techniques used by the authors in the current paper in Cell would have eliminated UCP2 in hypersecretion of insulin. However, the rapid insulin secretory response to glucose was significantly enhanced multiple tissues in addition to the ␤ cell, it would seem appropriate to consider the possibility that the mechain ob/ob mice lacking UCP2, suggesting that the ability of the ␤ cell to respond to minute-to-minute fluctuations nism of glucose lowering in ob/ob mice lacking UCP2 may be more complex than purely an increase in insulin in blood glucose may be enhanced. It will thus be important to prospectively study animals that can and cannot secretion, and could relate at least in part to UCP2 deficiency in other tissues.
compensate for insulin resistance to determine whether ␤ cell UCP2 levels differ in these groups over time. Many of the changes in the diabetic islet are induced by hyperglycemia and are reversible with experimental the insulin secretory failure that develops during the evolution of type 2 diabetes? UCP2 expression is eninterventions that lower glucose, suggesting that they are the result rather than the cause of hyperglycemia. hanced in obese, diabetic ob/ob mice. It also increases following exposure of pancreatic islets to free fatty acids The effects of lowering glucose in diabetic animals on ␤ cell UCP2 gene expression will need to be determined (Lameloise et al., 2001), a maneuver known to impair glucose-stimulated insulin secretion with chronic treatbefore UCP2 can be accepted as a major link between obesity, ␤ cell dysfunction, and type 2 diabetes. ment. Although these results raise the possibility that an increase in UCP2 expression may contribute to the The suggestion that pancreatic ␤ cell UCP2 is a useful target for the therapy of type 2 diabetes is exciting. ␤ cell dysfunction that occurs in insulin resistant animals or humans who develop type 2 diabetes, more informa-A reduction in UCP2 expression resulted in significant improvements in glucose levels and insulin secretion in tion is needed to substantiate this hypothesis and to establish a clear cause-and-effect relationship between diabetic ob/ob mice. However, overexpression of UCP2 in pancreatic islets from obese insulin resistant Zucker an increase in UCP2 and ␤ cell dysfunction.
There is evidence that increased UCP2 expression diabetic rats, another rodent model of type 2 diabetes, improved ␤ cell function (Wang et al., 1999) . The results may not impair ATP generation in muscle. In muscle, thyroid hormone increases UCP2 expression at the mesof the latter study are at variance with the study by Chan et al. (1999), which concluded that overexpression of sage and protein levels and also increases ATP production (Short et al., 2001 ). Although these results, which UCP2 induced by adenovirus in normal islets leads to inhibition of insulin secretion, a result consistent with were obtained in isolated mitochondria from muscle, cannot be extrapolated to indicate that UCP2 does not the present study in Cell. Whether these discrepancies relate to specific characteristics of the Zucker diabetic impair ATP generation in the pancreatic ␤ cell, they nevertheless raise the possibility that the functional efislets compared to normal rat islets or reflect differences between in vivo and in vitro models is uncertain. Howfects of increased UCP2 expression may not be completely understood.
ever, it will be important to confirm in other models that the desired therapeutic outcome in diabetes is a The presence of insulin resistance evokes a compensatory increase in the secretion of insulin (Polonsky et decrease in UCP2 expression in the pancreatic ␤ cell. While inhibition of ␤ cell UCP2 may lead to an increase al., 1996). The resulting hyperinsulinemia is responsible for maintaining normal blood glucose concentrations in in insulin secretion, there is evidence that in peripheral tissues such as muscles, the desired therapeutic outthe face of diminished peripheral insulin action. In most come may be an increase in uncoupling protein. It has been shown (Li et al., 2000) that an increase in UCP1 expression in muscle protects mice from diet-induced weight gain due to increases in peripheral energy expenditure. It thus may be necessary to develop tissue-specific approaches in which it would be possible to achieve a decrease in uncoupling protein in the pancreatic ␤ cell in order to stimulate insulin secretion and a simultaneous increase in uncoupling protein in peripheral tissues to promote weight loss and energy expenditure in overweight, insulin-resistant individuals.
In summary, UCP2 appears to affect the degree of uncoupling of respiration and oxidative phosphorylation in the pancreatic ␤ cell, thereby serving an important regulatory role in insulin secretion. Additional studies are needed to confirm the hypothesis that an increase in UCP2 expression is an important trigger in the failure of ␤ cell compensation for insulin resistance, a poorly understood event that is critical to the development of type 2 diabetes.
